PTPRC and neoplasm: Following CEBPδ-siRNA treatment, fluorescently labeled liver CD45+ cells from tumor-free and tumor-bearing mice were injected into the tail veins of individual mice, and CD45+ cell accumulation in the liver and lungs was quantified.